Yet again, Rottapharm Biotech scientists’ expertise and passion for osteoarthritis trials is at the service of integrated information. Read their outstanding systematic review and meta-analysis recently published on JAMA.
Association of Pharmacological Treatments With Long-term Pain Control in Patients With Knee Osteoarthritis: A Systematic Review and Meta-analysis.
Gregori D, Giacovelli G, Minto C, Barbetta B, Gualtieri F, Azzolina D, Vaghi P, Rovati LC.
JAMA. 2018 Dec 25;320(24):2564-2579
In this systematic review and network meta-analysis of 33 pharmacological interventions that included 22,037 patients with knee osteoarthritis in 47 randomized clinical trials lasting at least 12 months, Rottapharm Biotech scientists answer the following question: What is the association of available medications with long-term disease control in knee osteoarthritis?
Click here to access the online paper on JAMA